Facebook
Twitter
LinkedIn
ForwardTopics of Note
Course Director: Devyani Lal, M.D.
Mayo Clinic COVID-19: Expert Insights & Strategies Online CME provides concise updates related to COVID-19 through convenient, pre-recorded webinars. This online CME course will provide learners with the latest updates and strategies to protect themselves and their communities, and to provide treatment and mitigation information to enable healthcare workers to better manage cases and mortality rates. Topics include appropriate community- and personal-level protective and mitigating efforts; therapeutics; correct usage of personal protective equipment (PPE); and discussion of special scenarios healthcare workers may face.
Please see the "Program" tab for a summary of the segments available in the Topics of Note category.
This education is part of a larger curriculum of COVID-19 education and is supported in part by an independent medical education grant from Pfizer Inc. and is in accordance with ACCME guidelines. Click to view the full course contents.
Target Audience
Healthcare workers of all specialties who are being impacted by COVID-19, including physicians, research scientists, physician assistants, nurse practitioners, nurses, and anyone with a particular interest in prevention, treatment, and patient care.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Describe COVID-19 clinical features, virus characteristics, disease pathogenesis, multi-systemic effects, laboratory testing, factors in increased morbidity and causes of mortality
- Identify criteria for PCR testing, antibody serology and interpretation of test
- Recommendation strategies for caregivers and providers managing patients with COVID-19 at home; tele-monitoring COVID-19 patients
- Define methods for for managing COVID-19 positive and under-investigation patients in the hospital setting
- Describe aerosol generating procedures in the hospital in outpatient and inpatient settings during the pandemic
- Identify trategies for preventing transmission in healthcare workers overall and high risk workers (emergency department physicians, anesthesiologists, respiratory therapists, pulmonologists, otolaryngologists, etc.)
- Identify strategies for prevention of transmission/mitigation in the community
- Describe investigational treatments and trials (with addition of significant results as they become available) as well as emerging strategies (e.g. prone ventilation)
- Recommend oxygenation strategies in severely sick COVID-19 patients: Mechanical ventilation, ECMO, transfusion etc.
- Apply guidance for managing special patient populations during the COVID-19 pandemic: pregnant patients, patients with acute emergencies, patients with immunodeficiency, patients undergoing cancer treatment
- Implement cross-training/retraining on COVID-19 relevant procedures (e.g. ventilator management)
- Describe guidelines on the correct use, donning and doffing for personal protective equipment (PPE)
- Implement telemedicine solutions for training and patient care
Utilization of this Mayo Clinic online (enduring materials) course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be in this course.Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
The Mayo Clinic COVID-19: Expert Insights and Strategies Online CME Course brings together pre-recorded lectures and podcasts to offer a wide array of topics surrounding COVID-19. This course will continually expand to offer updated information. Please mark it as a "favorite" and check back for new and updated offerings.
COVID-19 information evolves daily. The views and perspectives shared in these resources are presented based on information available at the time of recording.
This education is part of a larger curriculum of COVID-19 education and is supported in part by an independent medical education grant from Pfizer Inc. and is in accordance with ACCME guidelines. Click to view the full course contents.
Program - Topics of Note:
 | Smoking and COVID-19: For Better or for Worse? Smoking is still the leading cause of death in the United States and in the world. J. Taylor Hays, M.D., a Mayo Clinic General Internist and Director of the Mayo Clinic Nicotine Dependence Center, discusses recent observational research displaying trends of less severe disease progression with COVID-19 in smokers, reasons why an inverse correlation between smoking prevalence and COVID-19 infection may be observed, and how clinicians should respond. |
 | COVID-19 and Bioethics: The Toll on Humanity and Systems - Online CME Course COVID-19 and Bioethics: The Toll on Humanity and Systems is an online CME course produced by the Mayo Clinic Institutional Review Board and Center for Bioethics. This activity will focus on the impact of the coronavirus pandemic on the healthcare system through specific examination of the effects on the workforce, research and the regulatory environment, vaccines, potential cures, and epidemiologic tracking. The Mayo Clinic experience and adaptive response to the pandemic will be highlighted. |
 | Perceptions of COVID-19 in Minorities - Online CME Course This presentation covers how COVID-19 has impacted Black, indigenous and other communities of color are negatively impacted by social determinants. Richard O. White, M.D., a Mayo Clinic internist, and community members discuss immediate concerns, obtaining PPE, testing and support needs, as well as other social determinants brought to light by the pandemic. |
 | Minorities in Clinical Trials - Online CME Course In this presentation, Mayo Clinic experts discuss how underrepresentation of minority groups in clinical trials affects the quality of research. They highlight how important it is to have a wide and varied participant pool in research efforts, with a special emphasis on COVID-19 research. |
 | 94th Annual Clinical Reviews - Online CME Course The 94th Annual Clinical Reviews seeks to update primary care providers on the latest recommendations involving medical subspecialties. The course provides a comprehensive program of lectures on topics of general interest in medicine, surgery, and pediatrics relevant to clinical practice. |
 | Healthcare During the COVID-19 Pandemic - Panel Discussion A Mayo Clinic expert panel discusses barriers that patients have faced throughout the COVID-19 pandemic, and present scenarios reflecting the importance of ongoing care. They also share ideal safety measures adopted by healthcare institutions. |
 | Coding and Billing for the COVID-19 Patient: What You Need to Know Click here for more information |
 | Balancing the Needs of Family, Work & Well-Being Click here for more information |
 | Healthcare Disparities and COVID-19: Medical Specialty Panel 1.00 Hour - Video Mayo Clinic experts from the Dermatology, Palliative Care, Nephrology, and Oncology specialties discuss healthcare disparities in their respective fields and how it relates to COVID-19. The panel members discuss the health disparities before COVID-19 as well as what they are seeing in the middle of the pandemic. Click here for more information |
 | Healthcare Disparities and COVID-19: Surgical Perspective Panel 1.00 Hour - Video Mayo Clinic experts from the Otolaryngology, Gynecology, Nephrology, and Anesthesiology specialties discuss healthcare disparities in their respective fields and how it relates to COVID-19. The panel members discuss the health disparities before COVID-19 as well as what they are seeing in the middle of the pandemic. Click here for more information |
 | COVID-19: Where do we go from here? 0.75 Hour - Video Angela M. Donaldson, M.D. of the Department of Otolaryngology at Mayo Clinic in Florida discusses the next steps for this pandemic with her panel of experts. The panel members explain benefits and barriers to telemedicine, contact tracing, and partnerships for community health. Each member discusses what they have learned from their institutions to help everyone cope with COVID-19. This presentation provides an overview of how communities can respond to the pandemic moving forward. Click here for more information |
 | COVID-19 Virtual Clinic - Mayo Clinic Experience 0.50 Hour - Video Katherine Walsh, MPAS, P.A.-C., M.P.H. and her team at Mayo Clinic in Florida created a virtual clinic for COVID-19 positive patients to keep beds available at the hospital. This presentation explains how it was implemented and the best practices for virtual patient care during this pandemic. It explores the benefits and hurdles for creating a virtual clinic. Click here for more information |
 | COVID-19: Essentials for the Healthcare Worker - Online This online CME course covers the COVID-19 disease, appropriate community level and personal level protective and mitigating efforts, therapeutics, and correct usage personal protective wear as well as discussing special scenarios. Click here for more information |
 | COVID-19: An Overview - Disease, Preparedness, Response and Treatment |
 | Supply Chain Considerations for Delivering the COVID-19 Vaccine: Webinar Session 13 Health care officials around the world are preparing to roll out a vaccine against COVID-19. In this webinar, Mayo Clinic experts will discuss logistical considerations and supply chain challenges for delivering and distributing the vaccine. Topics include overcoming vaccine hesitancy; ensuring vaccines reach the high-priority groups first; administration of multiple vaccine doses; and management of adverse effects. |
 | COVID-19 Leadership Strategies for 2021 : Session 12 As we move into 2021, the COVID-19 pandemic will continue to place extraordinary demands on today’s health care leaders. In this one-hour webinar, Mayo Clinic physician leaders and executives will discuss Mayo’s ongoing response to the COVID-19 pandemic, vaccination deployment plans, supply chain implications, the importance of vigilance and resilience in leaders and teams, and lessons leaders can use to effectively guide their institutions through this health crisis in the present and future. |
 | COVID-19 Challenging Conversations: Webinar Session 11 Thanks to uncertainty, high emotions, politicization and fatigue, communication with patients and families during the COVID-19 pandemic can be difficult. Experts from the Office of Patient Experience at Mayo Clinic discuss topics including delivering bad news from a distance; engaging employees and patients in masking and distancing measures; prioritizing bedside manner; and empathically responding to disagreement and derision. |
 | COVID-19 Vaccine Development: Webinar Session 10 Gregory A. Poland, M.D., an infectious diseases and vaccine specialist, and other Mayo Clinic experts will discuss development and dissemination of a vaccine against COVID-19, as well as how COVID-19 may affect the coming flu season. |
 | Responding to Workforce Management Issues in the COVID-19 Pandemic: Webinar Session 9 Mayo Clinic experts from Legal, Occupational Health and Human Resources will discuss employment issues related to COVID-19. |
 | Health Disparities in the COVID-19 Pandemic: Webinar Session 4 The COVID-19 pandemic has disproportionately impacted some socioeconomic and demographic groups. Experts discuss health disparities and potential solutions in terms of direct outcomes from SARS-CoV-2 infection; exacerbation of pre-existing inequities in health care; and indirect effects due to societal changes during this time. |
 | Pharmacists on the Frontlines: COVID-19 Q&A Since the emergence of SARS-CoV-2 pandemic, the practice of pharmacy has been altered to some degree in most, if not all, facets and pharmacists have been engaged in many aspects of the pandemic response. A panel consisting of pharmacists from a wide range of practice specialties will answer audience questions regarding their experiences in the COVID-19 response including treatment algorithm development, investigational drugs, healthcare incident command response, and patient care in the emergency department, critical care, and pediatric settings. |
 | Mental Health – Joy & Well-Being This course addresses mental health issues surrounding COVID-19. This one-hour program discusses leadership during challenging times, stress and anxiety management, and improving joy and well-being at work. |
 | Inequities Exposed by COVID-19 This segment includes two Grand Rounds discussions on the non-clinical factors that impact the mortality rates among members of racial and ethnic minority communities, and the benefits of collecting and reporting COVID-19 data by gender and ethnicity. Both sessions address similar topics on longstanding health disparities highlighted by the COVID-19 pandemic from the different perspectives of multidisciplinary panelists.. |
 | Mayo Clinic Q&A - COVID-19 - How Messenger RNA Vaccines Work (Podcast Episode 56) The first COVID-19 vaccines to reach the market are likely to be messenger RNA vaccines, or mRNA. According to the Centers for Disease Control and Prevention, mRNA vaccines work by teaching cells in the body how to make a protein that triggers an immune response. Unlike many vaccines that use a weakened or inactivated form of a virus, mRNA vaccines do not use the live virus that causes COVID-19. |
 | Mayo Clinic Q&A - COVID-19 - Managing the COVID-19 Surge (Podcast Episode 55) The current COVID-19 surge numbers could worsen in coming days as experts prepare for a post-Thanksgiving holiday increase in cases. Increased positivity rates lead to more people needing hospitalization, straining the health care system and medical staff. On the Mayo Clinic Q&A podcast, Dr. Elie Berbari, chair of the Division of Infectious Diseases at Mayo Clinic, explains how Mayo Clinic is managing staff, supplies and space during the COVID-19 surge. |
 | The Enigma of COVID-19 Long Haulers (Podcast Episode 54) What causes some patients to develop Long Haul COVID-19? Dr. Raymund Razonable discusses what the current data is showing and what we’re hoping to learn from future research. |
 | Mayo Clinic Q&A - COVID-19 - Mayo Clinic Q&A - How Do Antiviral Drugs Work? (Podcast Episode 52) Antiviral drugs are medicines that fight against viruses in the human body by impeding the infection process. Antivirals are commonly used to treat HIV/AIDS, influenza, herpes, and hepatitis B and C. The antiviral, Remdesivir, which was originally developed to fight Ebola, is now being used to treat COVID-19. On this Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains how antivirals work to shorten the course of the disease. |
 | Mayo Clinic Q&A - COVID-19 - Mayo Clinic Q&A - Bringing COVID-19 Vaccines to the Public (Podcast Episode 51) Once a vaccine to prevent COVID-19 is approved, there will be logistics to consider. For example, who will receive the vaccine first, and how can the supply chain safely deliver the vaccine to 330 million Americans and potentially more than 7 billion people worldwide? In addition, multiple vaccines may be brought to market within weeks to months of each other, confusing consumers. On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, explains the challenges of rolling out a COVID-19 vaccine. |
 | Mayo Clinic Q&A - COVID-19 - Essential Updates with Dr. Poland (Podcast Episode 50) On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, covers the latest news on the COVID-19 pandemic. Dr. Poland gives an update on progress towards a vaccine for COVID-19, discusses therapies for treating the virus and shares research on how effective face masks and physical distancing are in fighting the spread of the disease. |
 | Mayo Clinic Q&A - Back-to-School Recommendations (Podcast Episode 49) Whether in person, online or a hybrid model of education, families and school districts are planning for how to safely teach students during the COVID-19 pandemic. No matter which plan is chosen by communities, this school year will be challenging. On the Mayo Clinic Q&A podcast, Dr. Nipunie Rajapakse, a pediatric infectious disease specialist at Mayo Clinic, discusses how students, teachers and staff can use public health measures already in place to minimize the risk of exposure to the virus and reduce community spread of COVID-19. |
 | Serology Testing for COVID-19 (Podcast Episode 47) Elitza Theel, Ph.D., Laboratory Director of the Infectious Diseases Serology Laboratory at Mayo Clinic, led the efforts to evaluate and implement the serologic antibody test for COVID-19. She gives an overview of Mayo Clinic’s COVID-19 antibody test, as well as the role of antibody testing during the pandemic, and how sensitivity, specificity, and prevalence play a large role in the positive predictive value of a test. |
 | Physician Leaders and the Science of Health Care Delivery (Podcast Episode 46) What are population centered care and health? How do we best use rationed resources within our health care system to most effectively meet these needs? Dr. Lisa McGee discusses the Science of Health Care Delivery, the impact mass media messages have had on the current COVID-19 pandemic, and how we can use the information we have about population centered health to address key influential components of SARS-CoV-2’s continual spread. |
 | There Is No Win-Win (Podcast Episode 45) Novel viruses causing outbreaks tend to do one of three things: disappear completely, become endemic in certain areas, or roll through populations with ongoing transmission until herd immunity is achieved or an effective vaccine is developed. Pritish K. Tosh, M.D., states, "If natural infection doesn't cause long-lasting protective immunity or the vaccines don't do the same, this thing could be with us for a long time." Take a walk through the past 100 years of pandemics as Dr. Tosh draws comparisons and lessons learned. |
 | Healthcare Disparities and Systemic Racism (Podcast Episode 43) Black, Latino and Native American populations have been disproportionately affected by COVID-19. Underlying health inequities have been a major contributor. Kenneth G. Poole, Jr., M.D., M.B.A., discusses social determinants of health and how these combined with systemic racism, predating COVID-19, laid the groundwork for the suffering we're seeing unfold. What can we do to address it effectively? Click here for more information |
 | Breaking Down the Impact of Smoking in COVID-19 – Part 2 (Podcast Episode 41) Is the act of smoking a risk factor for transmission? Does nicotine protect against severe COVID-19? J. Taylor Hays, M.D., and Robert Vassallo, M.D., discuss what is currently known about the risks of smoking in regard to COVID-19 and treatment of patients who smoke during the pandemic. |
 | Breaking Down the Impact of Smoking in COVID-19 – Part 1 (Podcast Episode 40) Is smoking a risk factor for severe disease in COVID-19? How accurate is the documentation of smoking in COVID-19 cohorts currently published? What role should a smoking history play in the prognosis and management of COVID-19? J. Taylor Hays, M.D., and Robert Vassallo, M.D., discuss the prevalence of smoking worldwide, the impact of documentation, and the role smoking may play in COVID-19. |
 | The Enduring Power of Compassion (Podcast Episode 38) "At a time when most of the world in one way or another is suffering, it seems relevant to talk about ways to relieve some of that suffering and to help," says David J. Rosenman, M.D. Studies have shown that patients value empathy over sympathy, and compassion over empathy. While measures to protect ourselves and understand the spread of COVID-19 and the clinical presentation of the disease are underway, the inconsistency of information across sources brings greater uncertainty for our patients and at times ourselves. Dr. Rosenman discusses what compassion is and the importance of compassion as a tool to help us and our patients feel better mentally and physically. He recommends practicing self-compassion and will step through the practices of self-kindness, common humanity and mindfulness. |
 | Movement is Medicine (Podcast Episode 37) The world was already facing an epidemic of inactivity prior to the emergence and spread of SARS-CoV-2. Some have been able to focus more on self-care and fitness while under stay-at-home measures, but with the necessity of social distancing and the widespread closure of fitness centers others have encountered significant challenges. What is the real cost of inactivity? Whether it's the "Quarantine 15" or the psychological effects of being isolated in a world constantly changing, Edward R. Laskowski, M.D., shares one of the most effective treatments you can recommend to your patients. Click here for more information |
 | A Comprehensive Update on COVID-19 (Podcast Episode 36) Up to about 50% of people infected with SARS-CoV-2 are asymptomatic spreaders. About 80% of those who are symptomatic, developing COVID-19, have mild disease displaying dry cough, fever and fatigue. The resulting 20% of symptomatic patients account for those who develop progressive respiratory distress and sometimes multiorgan failure, among other complications. We're learning more about anosmia, cardiac injury and COVID toes. What's known about COVID-19 and SARS-CoV-2 continues to evolve. Raymund R. Razonable, M.D., walks through a recently published update on the management of COVID-19. |
 | COVID-19 Transmission Risks and Precautions (Podcast Episode 33) According to the Centers for Disease Control and Prevention, the most common mode of transmission for COVID-19 is through close contact from person to person. While it is possible to get COVID-19 by touching a surface or object that has the virus on it and then touching your own mouth, nose or possibly your eyes, this isn't thought to be the main way the virus spreads. Gregory A. Poland, M.D., an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, discusses virus transmission and steps to take to keep yourself safe. Click here for more information |
 | Addressing Health Disparities Amplified by COVID-19 (Podcast Episode 30) Minorities are being affected disproportionately by the COVID-19 pandemic. Early data show that African Americans and other ethnic minorities in the U.S. have contracted COVID-19 at a higher rate and experience greater sickness and a higher death rate than other Americans. On the Mayo Clinic Q&A podcast, Irene G. Sia, M.D., a Mayo Clinic infectious diseases expert, and Mark L. Wieland, M.D., a Mayo Clinic community internal medicine physician, discuss ethnic disparities and COVID-19, including research being done with the Rochester Healthy Community Partnership. Click here for more information |
 | Scaling Clinical Trials Through Teamwork (Podcast Episode 25) Thanks to its combination of practice, education and research, Mayo Clinic has a strong foundation to respond quickly to a medical crisis such as COVID-19. As the SARS-CoV-2 virus spread worldwide, a research task force was formed at Mayo Clinic to review and approve research proposals related to the virus and the disease it causes. On the Mayo Clinic Q&A podcast, Andrew D. Badley, M.D., chair of Mayo Clinic's COVID-19 Research Task Force, gives an update on COVID-19 research activities at Mayo Clinic. |
 | Ask MayoExpert COVID-19 Navigator (Podcast Episode 24) Wish you could find the easily digestible evidence-based information you're looking for with just a few clicks? AskMayoExpert COVID-19 Navigator is a free and open-access point-of-care resource containing consensus-based clinical recommendations, protocols and best practices. Mayo Clinic experts have done the reviews and they've done the synthesis, so you can quickly read what you need to know and get back to your patients. Scott D. Eggers, M.D., lays out how AskMayoExpert COVID-19 Navigator was formed, how it's being maintained, and what you can expect moving forward. |
 | Pets, Ultraviolet Light and Herd Immunity (Podcast Episode 18) Gregory A. Poland, M.D., an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group, answers listeners' coronavirus questions. Topics include pets and COVID-19, ultraviolet light and viruses, and herd immunity. |
Course Director
 | Devyani Lal, M.D. |
|
|
Topic/session specific faculty are detailed under each course page under the Faculty tab.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 29.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 2.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 29.75 AMA PRA Category 1 Credit™
- 2.50 ANCC
- 29.75 Attendance
Cancellation and Refund Policy:
Request for cancellations must be submitted in writing to cme@mayo.edu. When cancelling a registration for a course 14 days or more before the course start date, a full refund (minus a $75 administrative fee) will be issued in the same form of payment the registration was received. No refunds are granted less than 14 days before the course start date.
Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.